Grow Co., Inc. v. Chokshi

37 A.3d 1155, 424 N.J. Super. 357
CourtNew Jersey Superior Court Appellate Division
DecidedMarch 7, 2012
DocketA-0026-10T4
StatusPublished
Cited by20 cases

This text of 37 A.3d 1155 (Grow Co., Inc. v. Chokshi) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Grow Co., Inc. v. Chokshi, 37 A.3d 1155, 424 N.J. Super. 357 (N.J. Ct. App. 2012).

Opinion

37 A.3d 1155 (2012)
424 N.J. Super. 357

GROW COMPANY, INC., Plaintiff-Appellant/Cross-Respondent,
v.
Dilip CHOKSHI and Pharmachem Laboratories, Inc., Defendants-Respondents/Cross-Appellants.

Docket No. A-0026-10T4

Superior Court of New Jersey, Appellate Division.

Argued February 7, 2012.
Decided March 7, 2012.

*1156 Dennis F. Gleason, Roseland, argued the cause for appellant/cross-respondent (Carella, Byrne, Cecchi, Olstein, Brody & Agnello, attorneys; Carl R. Woodward, III, and Mr. Gleason, of counsel; Mr. Woodward, Mr. Gleason and Vincenzo M. Mogavero, on the brief).

*1157 Richard L. Ravin, Paramus, argued the cause for respondents/cross-appellants (Hartman & Winnicki, attorneys; Mr. Ravin, of counsel; Mr. Ravin, Richard E. Kummer and Shifra Herzberg, on the brief).

Before Judges CARCHMAN, FISHER and BAXTER.

The opinion of the court was delivered by

FISHER, J.A.D.

In this appeal, we review the Chancery judge's disposition of numerous factual disputes following a nonjury trial, as well as the judge's subsequent ruling on defendants' counsel fee claim. Applying our deferential standard of review, we find no reason to intervene and affirm in all respects.

Because this case was previously before us, there is no need to repeat what was thoroughly discussed about the nature and specifics of the parties' competing claims on that earlier occasion. See Grow Co., Inc. v. Chokshi, 403 N.J.Super. 443, 959 A.2d 252 (App.Div.2008). We need only briefly summarize for present purposes that plaintiff Grow Company, Inc., a health food manufacturer, commenced this suit against a former employee, defendant Dilip Chokshi, and a competitor, defendant Pharmachem Laboratories, Inc., alleging misappropriation of its trade secrets aided through Chokshi's breach of a confidentiality agreement he had entered into with plaintiff in 1982 while in plaintiff's employ.

Defendants counterclaimed, asserting that plaintiff's suit was barred by the terms of a 2001 settlement agreement, which ended a suit filed by plaintiff against Chokshi and Bio-Foods, Ltd., another competitor. The 2001 settlement agreement contained plaintiff's covenant not to sue and stipulated that a breach of that covenant would authorize an award of counsel fees to the parties to that suit and other generally defined persons or entities. As a result, defendants—believing plaintiff had commenced this suit in violation of the 2001 settlement agreement—sought attorneys' fees. Defendants also demanded a judgment declaring the 1982 confidentiality agreement invalid.

The earlier appeal in this case was prompted by the prior Chancery judge's grant of a partial summary judgment, in which the judge: found plaintiff's claims were barred by the 2001 settlement agreement; dismissed the claim for a declaratory judgment concerning the 1982 confidentiality agreement; and concluded that plaintiff's breach of the 2001 settlement agreement permitted an award of counsel fees to Chokshi but not to Pharmachem. The judge did not, however, proceed to quantify the counsel fees he believed were due but instead dismissed that claim without prejudice and expressly authorized that claim's renewal in a later suit unhampered by the entire controversy doctrine. Id. at 454, 959 A.2d 252. Believing finality had been achieved in this manner, the parties appealed. We found, however, that the dismissal without prejudice only created the illusion of finality and concluded that the appeal was premature. Id. at 461-62, 959 A.2d 252. Notwithstanding our criticism of the manner in which the case came before us, we determined that the interests of justice were better served by a review of the interlocutory rulings questioned in the appeal, id. at 462-63, 959 A.2d 252, and, with one exception,[1] vacated *1158 the summary disposition of the parties' claims, id. at 479, 959 A.2d 252.

Following our remand, a trial before a different Chancery judge took place over the course of fifteen days in October and November 2009. In a thorough written opinion, the Chancery judge found: the 1982 confidentiality agreement was void and unenforceable; plaintiff failed to prove that Chokshi disclosed any of plaintiff's trade secrets to Pharmachem notwithstanding its efforts to ensure the confidentiality of its manufacturing processes; and Pharmachem was entitled to counsel fees as a result of plaintiff's breach of the 2001 settlement agreement—even though Pharmachem was not a party to the suit that resulted in the 2001 settlement agreement—because the parties to that agreement had broadly defined the class of persons and entities entitled to benefit from its terms.

Chokshi and Pharmachem thereafter applied for an award of counsel fees, based not only on the contractual stipulation in the 2001 settlement agreement, but also on the frivolous litigation statute, N.J.S.A. 2A:15-59.1. The Chancery judge rejected the argument that plaintiff violated the frivolous litigation statute and further determined that defendants were not entitled to an award of counsel fees for all their efforts in this case. Instead the judge found three areas in which counsel fees could be awarded.

First, the judge found it was appropriate to award fees for work expended "prior to the appeal [that] was necessary on the issue of whether the 2001 settlement agreement was a general release." Second, the judge found defendants were entitled to an award of reasonable fees in "establishing the efficacy of the 2001 settlement agreement from the time of the filing of the verified complaint up until the point where the plaintiff abandoned that position on appeal." And, third, the judge found defendants were entitled to fees and expenses related to defeating the assertion that Pharmachem was not entitled to relief pursuant to the 2001 settlement agreement.

Recognizing the scope of this undertaking in light of the case's age and the extraordinary amount of time expended by counsel that required analysis, the Chancery judge appointed an expert to make recommendations on defendants' counsel fee claim. The expert reviewed the voluminous materials submitted and drew conclusions regarding the reasonableness of the hourly rates charged and the reasonableness of the amount of time expended as limited by the judge's rulings as to the scope of the award (hereafter "the award categories"). Specifically, the expert approached the matter by way of a three-step process.

The expert first reviewed counsel's invoices and assigned each entry a task code, following which he aggregated the hours expended by task code and ascertained the cost of each task by multiplying those hours by the reasonable hourly rates of the timekeepers. In accomplishing this, the expert expressed satisfaction, based on his review, that counsel's documentation was prepared with "considerable care and diligence."

*1159 In the second step, the expert isolated the portions of the total fees identified for each coded task in the first step in light of the award categories identified by the judge. This required, as the expert explained, "a review of thousands of pages of written or transcribed documents developed or created through the course of the litigation, and a determination of what portion of each document, if any, related to any of" the categories identified by the judge as permitting an award.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Peter J. Decarlo v. Antonio D'angelo
New Jersey Superior Court App Division, 2026
Ryan Van Nostrand v. Sofia Van Nostrand
New Jersey Superior Court App Division, 2025
Steven J. Karvellas v. Stephen E. Sweeney
New Jersey Superior Court App Division, 2025
Eugenia Dejesus v. Ali Abdi
New Jersey Superior Court App Division, 2025
Divyajit Mehta v. Emanuel Hedvat
New Jersey Superior Court App Division, 2025
339 River Road Partners, LLC v. 339 River Road Holdings, LLC
New Jersey Superior Court App Division, 2025
Keona Palmer v. Flagship Resort Development Corp., Etc.
New Jersey Superior Court App Division, 2025
A.K. v. S.K.
New Jersey Superior Court App Division, 2025
Chelsea Anzures v. Morris County Juvenile Detention Center
New Jersey Superior Court App Division, 2023
Wear v. Selective Ins. Co.
190 A.3d 519 (New Jersey Superior Court App Division, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
37 A.3d 1155, 424 N.J. Super. 357, Counsel Stack Legal Research, https://law.counselstack.com/opinion/grow-co-inc-v-chokshi-njsuperctappdiv-2012.